5Papapetropoulos S,Singer C. Botulinum toxin in movement disorders[J]. Semin Neurol,2007,27 (2) : 183-- 194.
6Frei K,Truong DD,Dressler D. Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations[J]. Eur J Neurol,2006,13(1) :30--35.
7Mejia NI,Vuong KD,Jankovic J. Long -term botulinum toxin efficacy, safety, and immunogenicity[J].Mov Disord, 2005, 20(5) :592--597.
8Jost WH,Kohl A. Botulinum toxin: evidence-- based medicine criteria in blepharospasm and hemifacial spasm[J].J Neurol, 2001,248(1) :21--24.
9Hsiung GY, Das SK, Ranawaya R, et al. Long-- term efficacy of botulinum toxin A in treatment of various movement disorders over a 10--year period[J]. Mov Disord,2002,17(6):1 288--1 293.
10Snir M,Weinberger D, Bourla D,et al. Quantitative changes in botulinum toxin a treatment over time in patients with essential hlepharospasm and idiopathic hemifacial spasm[J].Am J Ophthalmol, 2003,136 ( 1 ) : 99 -- 105.
